Why the study?
Pulmonary embolism associated with malignant neoplasms frequently complicates oncological processes, decreases survival and quality of life, and can present as the debut of active malignancy.
Demonstrates an individualized interventional strategy and the importance of oncological screening in patients with unprovoked high-risk pulmonary embolism.
PE without clear risk factors may herald occult malignancy; leaves open optimal screening protocols in case series.
Pulmonary embolism (PE) associated with malignant neoplasms is a frequent complication of the oncological process and leads to a decrease in survival and quality of life of these patients. In some cases, pulmonary embolism can become the debut of a current active oncological disease, which requires increased cancer alertness in patients with PE without clear predisposing factors, especially in cancer risk groups. The article demonstrates a clinical case of an individualized approach to choosing an interventional strategy in a comorbid patient with high-risk PE. The tactics of active oncological screening made it possible to confirm a pulmonary embolism against the background of current prostate cancer.
No takes yet. Share an insight, caveat, or question.
Parkhomenko et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: